DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Nexus Surgical and Medicare Ltd (NEXUSSURGL) share price today?

Nexus Surgical and Medicare Ltd (NEXUSSURGL) is trading at ₹18.91 on the BSE, up 0.16% on the day. Source: DocStoX.

What is the PE ratio of Nexus Surgical and Medicare Ltd?

Nexus Surgical and Medicare Ltd has a price-to-earnings (PE) ratio of 20.8 in the Financial Services sector.

What is the market capitalisation of Nexus Surgical and Medicare Ltd?

Nexus Surgical and Medicare Ltd has a market capitalisation of approximately ₹11 crore.

Nexus Surgical and Medicare Ltd

NEXUSSURGL·BSE·Financial Services

₹18.91▲ +0.03 (+0.16%)

Financial Services · Finance

Debt-free and consistently profitable

Day₹18.30

₹19.90

52W₹13

₹2646%

Open

₹19.00

High

₹19.90

Low

₹18.30

Prev Close

₹18.88

Volume

3.6K

VWAP

₹19.14

Snapshot

Key fundamentals

Market Cap

₹11 Cr

P/E Ratio

20.78Fair

P/B Ratio

5.73

EPS

₹0.91

Book Value

₹3.29

ROE

46.76%Strong

ROCE

83.95%Efficient

Dividend Yield

0.00%

Debt / Equity

0.00Low

Face Value

₹10.00

52W High

₹25.50

52W Low

₹13.26

Sector

Financial Services

Industry

Finance

Expensive

Narrow moatVery High uncertainty

Fair value estimate

₹13

▼ 31.3%downside

Trading at ₹19 — 31% above our estimate

BearFair valueBull

₹11₹13₹15

/100

Business quality — Solid

Growth 50Profitability 69Efficiency 100Valuation 87

Plain English

Our view

Debt-free and consistently profitable
Virtually debt-free balance sheet

Strengths

Virtually debt-free balance sheet
Strong returns on equity (47%)
Capital is working hard (ROCE 84%)

How we got there

Fair value methods

Excess-return (book value)

47% ROE fading to 13% over ~10 yrs, on ₹3 book

₹13

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Not meaningful for financials

—

Analyst target

No analyst coverage

—

Blended fair value₹13

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet
Strong returns on equity (47%)
Capital is working hard (ROCE 84%)

Bear case

No notable red flags from the current metrics.

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

20.8Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

46.8%Strong

Above 15% is considered healthy for Indian equities

ROCE

84.0%Efficient

Above 18% means capital is working hard

Debt/Eq

0.00Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹11 Cr

P/B

5.73

EPS

₹0.91

Div Yield

—

What changed

Recent changes

No notable changes to report.

What matters

News impact

Overview

Valuation

Reasonable

P/E 20.8×

Growth

Strong

+72% rev CAGR

Profitability

Excellent

46.8% ROE

Financial health

Rock solid

D/E 0.00

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹69,805 Cr

Trades67

VWAP₹19.14

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+71.9%

+16.0%

10Y

+37.3%

Profit

+63.3%

+37.6%

10Y

+30.9%

EPS

+8.0%

+7.6%

10Y

+15.8%

Profile

Pros

Company is almost debt free.
Company has a good return on equity (ROE) track record: 3 Years ROE 53.8%

Watch-outs

Cons

Promoter holding is low: 18.7%

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Ownership was broadly stable versus the previous quarter. The QoQ column shows each group's change versus the prior quarter.

19%

Promoter

Promoters

18.7%0.00

Public

41.9%-1.52

FII / FPI

0.0%0.00

DII

0.0%0.00

Others

39.4%

Total shareholders

5,743-115 QoQ

Quarterly trend

Ownership over time

Q1 FY27

Promoter18.73%

Public41.90%

Others39.37%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1992, Nexus Surgical and Medicare Ltd deals in medical disposable, surgical equipment, pharmaceutical products[1]